Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...

Fifty people from Northern Colorado and the Boulder Valley were honored Thursday at BizWest’s 2026 “Most Influential Business Leaders” event and Book of Lists launch party at the Forge Event Center in ...

Harvard-trained Nigerian scientist, Dr Olakunle Jaiyesimi, speaks to IBRAHIM ADAM on how leaving Nigeria gave him an insight that expanded his professional capacity, among other issuesWhen did you ...